Investigation on in vitro metabolisms of peptide drug lxt-101 and its structural modified analogs

• In: SIG Bioavailability/Bioequivalence - Posters
• At: Beijing (China) (2007)
• Type: Poster
• Poster code: BB-P-032
• By: SUN, Huixian (Institute of Pharmacology and Toxicology, Beijing, China)
• Co-author(s): GUO, Lei (Institute of Pharmacology and Toxicology, BEIJING, China)
  ZHOU, Ning (Institute of Pharmacology and Toxicology, BEIJING, China)
  XIE, Jian-wei (Institute of Pharmacology and Toxicology, BEIJING, China)
  LIU, Ke-liang (Institute of Pharmacology and Toxicology, BEIJING, China)
  
• Abstract:

  OBJECTIVE In recent years, peptide drug has raised its wide applications in therapy based on its important functions on maintaining normal physical metabolism. For example, luteinizing hormone-releasing hormone(LHRH) is a small polypeptide with 10 amino acids, it has been employed to treat the diseases related to follicle-stimulating hormone(FSH)..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login